Doceree Honored 25 Healthcare Leaders at AI Awards
The AI Health 25 event recognized innovators in marketing, pharmaceuticals, and medical technology.
Updated on Sept. 24, 2026 in Healthcare
Live Poll
Do you trust that increased AI use in healthcare will improve patient outcomes?
Doceree hosted the AI Health 25 awards ceremony to celebrate individuals advancing medicine through artificial intelligence. The event recognized 25 leaders from sectors including pharmaceuticals and medical technology.
Why it matters
The ceremony highlights the growing influence of artificial intelligence in reshaping how medicine is developed, marketed, and delivered to patients. It showcases the contributions of executives from major industry players.
The program recognized exactly 25 honorees for their contributions to the health sector. The ceremony was held at the 102nd floor of the One World Observatory.
The players
Doceree
This company specializes in programmatic digital advertising solutions specifically for the global healthcare and life sciences industry.
Genentech
A biotechnology company that discovers, develops, and manufactures medicines for patients with serious or life-threatening diseases.
Johnson & Johnson
An American multinational corporation that develops medical devices, pharmaceuticals, and consumer packaged goods.
Eli Lilly
A global pharmaceutical company that creates medicines for diabetes, oncology, immunology, and neuroscience.
The details
The editorial team at Doceree selected honorees to represent the breadth of the healthcare industry, drawing from companies such as Genentech, Johnson & Johnson, and Eli Lilly. The evening included cocktail sessions and presentations at the New York City venue.
Timeline
Doceree hosted the AI Health 25 awards evening on September 23, 2026.
Market Landscape
The awards reflect a broader industry transition where major pharmaceutical firms are prioritizing AI integration to maintain competitive advantages. This shift mirrors the regulatory environment set by the FDA's Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices framework.
The event serves as an indicator of which companies are investing heavily in AI, which may influence future drug development pipelines and marketing strategies. Consumers may eventually see more personalized health information as these technologies become standard.
The takeaway
Artificial intelligence is moving beyond the research lab to become a core component of pharmaceutical marketing and commercial strategy. Industry participants should monitor these award-winning projects to identify emerging best practices in medical communication.
Further reading
For more on industry leadership trends, visit the Healthcare section.
Source note: This article includes information reported by Adweek.
Live Poll
Do you trust that increased AI use in healthcare will improve patient outcomes?
